A number of end points could be envisaged, including blood pressure and albuminuria reduction; adverse effects such as hyperkalemia, hypotension, and worsening renal function; and outcome benefits including cardiovascular disease events, renal disease progression, and, particularly in congestive heart failure (CHF) studies, prevention of hospitalization.
There are numerous factors to consider when selecting another agent in lieu of metformin including, but not limited to, overall efficacy in A1c reduction, adverse effect profile, cost, and patient preference.
Ideally, a comprehensive decision model for PD that can be applied to different treatment strategies should consider a large spectrum of clinically relevant outcomes and complications of the disease during a sufficiently long time horizon, including reduction of symptomatic progression; initial symptomatic improvement; or reduction of adverse effects, and improvement of HRQoL.
Advertisements were independently categorised into the following categories of claims: efficacy, reduction in adverse effects (safety), cost (reduced costs or better cost-effectiveness ratio), and dosage/convenience (simplified dosing or ease of use).
Atmospheric aerosol is linked to visibility reduction, adverse health effects and heat balance of the Earth, directly by reflecting and absorbing solar radiation and indirectly by influencing the properties and cloud processes and, possibly, by changing the heterogeneous chemistry of reactive greenhouse gases [1].
In psychological research, reduction of adverse effects of distraction is demonstrated when specifically multitasking is trained.
This is a dialogue between the clinician and patient about potential for atherosclerotic cardiovascular disease risk reduction benefits, adverse effects, drug-drug interactions, and patient preferences.
Almost all drug administration routes (parenteral, oral, nasal and ocular) have benefitted from micellar forms of drug in terms of either increased bioavailability or reduction of adverse effects [123].
These fourth-generation agents provide a real degree of therapeutic comfort in terms of stable activity, a reduction in adverse effects and a broad therapeutic spectrum, especially in myocardial ischaemia and potentially in congestive heart failure.
Nanoparticles (NP) are known for their specific accumulation in the inflamed tissues in the colon and may therefore allow a selective delivery to the site of inflammation including a reduction of adverse effects.
Titration to determine the best balance between the reduction of adverse effects and a satisfactory analgesia is challenging.
